$2.35
6.37% yesterday
Nasdaq, Jun 26, 10:08 pm CET
ISIN
US3632252025
Symbol
GALT
Sector
Industry

Galectin Therapeutics Inc. Target price 2025 - Analyst rating & recommendation

Galectin Therapeutics Inc. Classifications & Recommendation:

Hold
50%
Sell
50%

Galectin Therapeutics Inc. Price Target

Target Price $6.12
Price $2.35
Potential
Number of Estimates 3
3 Analysts have issued a price target Galectin Therapeutics Inc. 2026 . The average Galectin Therapeutics Inc. target price is $6.12. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 0 Analysts recommend Galectin Therapeutics Inc. to buy, 3 to hold and 3 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Galectin Therapeutics Inc. stock has an average upside potential 2026 of . Most analysts recommend the Galectin Therapeutics Inc. stock at Sell or hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share $ -0.76 -0.91
2.70% 19.74%
P/E negative
EV/Sales 4.68

3 Analysts have issued a Galectin Therapeutics Inc. forecast for earnings per share. The average Galectin Therapeutics Inc. EPS is

$-0.91
Unlock
. This is
26.39% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.93 29.17%
Unlock
, the lowest is
$-0.87 20.83%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.76 2.70%
2025
$-0.91 19.74%
Unlock
2026
$-1.13 24.18%
Unlock
2027
$-0.65 42.48%
Unlock

P/E ratio

Current -3.26 3.22%
2025
-2.59 20.65%
Unlock
2026
-2.08 19.69%
Unlock
2027
-3.60 73.08%
Unlock

Current Galectin Therapeutics Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
Locked
Locked Apr 02 2025
HC Wainwright & Co.
Locked
Locked
Locked Dec 27 2024
HC Wainwright & Co.
Locked
Locked
Locked Nov 15 2024
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
Locked
Apr 02 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Dec 27 2024
Locked
HC Wainwright & Co.:
Locked
Locked
Nov 15 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today